Discovery Assay Development of Biomarkers Predictive of Preterm Birth

June 2014 – Sera Prognostics, Inc. presented the development and analytical performance of a highly multiplexed and targeted mass spectrometry-based assay for biomarker discovery and subsequent clinical diagnostic development. Using this advanced MRM method, biomarkers were identified across multiple pathways of relevance to preterm birth.

American Society of Mass Spectrometry Presentation

Scroll to Top